News

The ongoing Phase 2b clinical trial evaluates efficacy on motor nerve conduction velocity, clinical outcomes, and visual acuity. "While there are many drugs available to patients and physicians

This approval was based on the impressive results of the registration study (Study 205), in which the once daily combination of 18 mg LENVIMA and 5 mg everolimus

Alprolix is the only recombinant factor IX Fc Fusion protein therapy for haemophilia B to offer people in the EU prolonged protection against bleeding episodes with fewer prophylactic

"We are very pleased that FDA has granted Fast Track designation for EG-1962 for the treatment of SAH," said Brian A. Leuthner, Edge’s Chief Executive Officer. "The FDA

A severe, rare, inherited disorder of the liver, PH1 often results in kidney failure, and there are no approved therapies for the disease. The U.S. Food and Drug

The company enforced a distribution restriction for particular products that have been part of, or considered by various states for their lethal injection protocols. The products include pancuronium

US states and territories can now apply to the Centers for Disease Control and Prevention (CDC) for funds to fight Zika locally. The CDC said $25m in preparedness

Mylan will pay $950m in cash up front and up to $50m in future payments. The deal adds about 25 branded and generic products, a 25-product pipeline and

"We are very pleased to progress to the Phase 2 portion of this trial evaluating FPA008 as a treatment for patients with PVNS, an orphan joint disease associated